AM-Pharma is a biopharmaceutical company focused on developing treatments for severe medical conditions, particularly through its proprietary compound ilofotase alfa for hypophosphatasia (HPP) and recombinant human alkaline phosphatase for acute kidney injury (AKI)
AM-Pharma is a biopharmaceutical company focused on developing treatments for severe medical conditions, particularly through its proprietary compound ilofotase alfa for hypophosphatasia (HPP) and recombinant human alkaline phosphatase for acute kidney injury (AKI).